Literature DB >> 14614396

Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs.

Judy Mouchawar1, Karin Valentine Goins, Carol Somkin, Elaine Puleo, Sharon Hensley Alford, Ann M Geiger, Stephen Taplin, Joyce Gilbert, Sheila Weinmann, Jane Zapka.   

Abstract

PURPOSE: To describe referral guidelines for hereditary breast and ovarian cancer (HBOC) counseling among a group of Health Maintenance Organizations (HMOs) and awareness of such among primary care clinicians.
METHODS: An organizational assessment of plan policies and a primary care clinician survey.
RESULTS: Five of the 7 HMOs reported having HBOC referral guidelines. Differences between plan's criteria included age of breast cancer onset, inclusion of male breast cancer, and second-degree relatives. Of the 91% clinicians responding, only half were aware of the HBOC guidelines. Awareness was higher in the plan with the most intense implementation effort (OR=3.0, 1.5-5.9) and among gynecologists (OR=2.8, 1.5-5.4).
CONCLUSIONS: Although HBOC counseling guidelines within participating HMOs identify persons for referral that can be easily incorporated into routine practice, continued work is needed to better understand how to help primary care providers identify high-risk persons, and new models of providing genetic services may need to be considered.

Entities:  

Mesh:

Year:  2003        PMID: 14614396     DOI: 10.1097/01.gim.0000093979.08524.86

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  6 in total

1.  Increasing utilization of cancer genetic counseling services using a patient navigator model.

Authors:  Alanna Kulchak Rahm; Anna Sukhanova; Jennifer Ellis; Judy Mouchawar
Journal:  J Genet Couns       Date:  2007-04       Impact factor: 2.537

2.  Use of a patient-entered family health history tool with decision support in primary care: impact of identification of increased risk patients on genetic counseling attendance.

Authors:  Adam H Buchanan; Carol A Christianson; Tiffany Himmel; Karen P Powell; Astrid Agbaje; Geoffrey S Ginsburg; Vincent C Henrich; Lori A Orlando
Journal:  J Genet Couns       Date:  2014-08-15       Impact factor: 2.537

Review 3.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

4.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

5.  From Research to Practice in OBGYN: How to Critically Interpret Studies in Implementation.

Authors:  Rebecca F Hamm; Michelle H Moniz
Journal:  Clin Obstet Gynecol       Date:  2022-03-31       Impact factor: 1.966

6.  Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.

Authors:  Douglas E Levy; Judy E Garber; Alexandra E Shields
Journal:  J Gen Intern Med       Date:  2009-05-20       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.